RECK and cholangiocarcinoma: Aspirin was able to upregulate RECK levels, inhibit MMP-2/MMP-9 activity, and reduce the number of invasive CCA cells through the inhibition of the Ras signaling pathway by reducing the phosphorylation of Akt/Erk/c-Jun in CCA cells [40].